2,2,2-Trifluoro-1-(5-methylpyridin-2-yl)ethanol, 98%, 10g

2-(Toluene-4-sulfonyl)-propionic acid hydrazide, 98.0%, 5g

4,6-Di-tert-butylpyrimidin-2-amine, 95%, 250mg

3-Bromo-9,9-dimethyl-9H-fluorene, 97.0%, 25g

5-Methylpyrazine-2-carbonitrile, 97.0%, 5g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 150, 5000 ml, 190 mm, 1 Piece

5,6,7,8-Tetrahydro-pyrazolo[1,5-a]azepin-4-one, 98%, 50mg

1-((1S,2S)-1-Hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol, 95.0%, 50mg

1-(3-METHYLPYRIDIN-4-YL)ETHANONE, 97.0%, 100mg

2,2-Difluoro-2-pyridin-2-ylethaneamine, 95.0%, 50mg

7-Ethoxy-2-naphthalenol, 95.0%, 5g

(+/-)-Isoborneol>90.0%(GC)25g

(R)-Ethyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 1g